Korotaeva, T.
Dina, O.
Holdsworth, E.
Fallon, L.
Milligan, G.
Meakin, S.
Wang, L.
Vasilescu, R.
Cappelleri, J. C.
Deodhar, A.
Funding for this research was provided by:
Pfizer
Article History
Received: 5 March 2021
Revised: 17 June 2021
Accepted: 13 July 2021
First Online: 28 July 2021
Change Date: 27 January 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10067-022-06069-3
Declarations
:
: Not applicable. The DSP™ complies with all relevant market research guidelines and legal obligations. Data were collected according to European Pharmaceutical Marketing Research Association guidelines and thus did not require ethics committee approvals.
: Using a check box, patients provided informed consent for use of their anonymized and aggregated data for research and publication in scientific journals. Data were collected in such a way that patients and physicians could not be identified directly; all data were aggregated and de-identified before receipt by Adelphi Real World.
: TK received research grants from Pfizer, and consultancy/speaking fees from Janssen, Pfizer, MCD, UCB, Novartis, Abbvie, Biocad, Lilly and Novartis-Sandoz.OD, LF, LW, RV, and JCC are employees of Pfizer Inc. and own stocks in Pfizer Inc.EH, GM, and SM are employees of Adelphi Real World. Adelphi Real World received funding from Pfizer Inc. for this analysis and manuscript development.AD received research grants and consultancy/speaking fees from Pfizer Inc.; he has participated in advisory boards for Pfizer Inc.